Caredx to report fourth quarter and full year 2021 financial results

South san francisco, calif., feb. 17, 2022 (globe newswire) -- caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients – today announced it will report financial results for the fourth quarter and full year 2021 after market close on thursday, february 24, 2022. company management will host a corresponding conference call beginning at 1:30 p.m. pacific time / 4:30 p.m. eastern time.
CDNA Ratings Summary
CDNA Quant Ranking